Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z)

DRUG2 trials

Sponsors

French National Agency for Research on AIDS and Viral Hepatitis, Liaquat National Hospital & Medical College

Conditions

AidsDrug Induced Liver InjuryHiv InfectionsTuberculosisTuberculosis (TB)

Phase 1

Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi

Not yet recruitingNCT07058090

Liaquat National Hospital & Medical CollegeDrug Induced Liver Injury, Tuberculosis (TB)

Start: 2025-07-31End: 2026-05-31Target: 410Updated: 2025-07-10

Phase 2

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

CompletedNCT00495326

French National Agency for Research on AIDS and Viral HepatitisAids, Hiv Infections, Tuberculosis

Start: 2007-12-31End: 2011-04-30Updated: 2012-02-15

Related Papers

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Antimicrobial Agents and Chemotherapy2014-03-2541 citations

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.

2013-02-2039 citations